Suppr超能文献

流感导致肺上皮离子通道活性降低,从而导致肺内液体动态平衡失调。

Influenza-mediated reduction of lung epithelial ion channel activity leads to dysregulated pulmonary fluid homeostasis.

机构信息

Department of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.

Department of Medicine, Division of Pulmonary, Allergy, and Critical Care, and.

出版信息

JCI Insight. 2018 Oct 18;3(20):123467. doi: 10.1172/jci.insight.123467.

Abstract

Severe influenza (IAV) infection can develop into bronchopneumonia and edema, leading to acquired respiratory distress syndrome (ARDS) and pathophysiology. Underlying causes for pulmonary edema and aberrant fluid regulation largely remain unknown, particularly regarding the role of viral-mediated mechanisms. Herein, we show that distinct IAV strains reduced the functions of the epithelial sodium channel (ENaC) and the cystic fibrosis transmembrane regulator (CFTR) in murine respiratory and alveolar epithelia in vivo, as assessed by measurements of nasal potential differences and single-cell electrophysiology. Reduced ion channel activity was distinctly limited to virally infected cells in vivo and not bystander uninfected lung epithelium. Multiple lines of evidence indicated ENaC and CFTR dysfunction during the acute infection period; however, only CFTR dysfunction persisted beyond the infection period. ENaC, CFTR, and Na,K-ATPase activities and protein levels were also reduced in virally infected human airway epithelial cells. Reduced ENaC and CFTR led to changes in airway surface liquid morphology of human tracheobronchial cultures and airways of IAV-infected mice. Pharmacologic correction of CFTR function ameliorated IAV-induced physiologic changes. These changes are consistent with mucous stasis and pulmonary edema; furthermore, they indicate that repurposing therapeutic interventions correcting CFTR dysfunction may be efficacious for treatment of IAV lung pathophysiology.

摘要

严重流感(IAV)感染可发展为支气管肺炎和水肿,导致获得性呼吸窘迫综合征(ARDS)和病理生理学改变。肺水肿和异常液体调节的根本原因在很大程度上仍然未知,特别是关于病毒介导的机制的作用。在此,我们表明,不同的 IAV 株通过测量鼻电位差异和单细胞电生理学,在体内降低了鼠类呼吸道和肺泡上皮中的上皮钠离子通道(ENaC)和囊性纤维化跨膜转导调节因子(CFTR)的功能。在体内,活性降低的离子通道活性明显仅限于受病毒感染的细胞,而不受旁观者未感染的肺上皮细胞的影响。多条证据表明,在急性感染期 ENaC 和 CFTR 功能障碍;然而,只有 CFTR 功能障碍在感染期后持续存在。ENaC、CFTR 和 Na,K-ATPase 的活性和蛋白水平在受病毒感染的人气道上皮细胞中也降低。ENaC 和 CFTR 的减少导致人气管支气管培养物和 IAV 感染小鼠气道的气道表面液体形态发生变化。CFTR 功能的药物矫正改善了 IAV 引起的生理变化。这些变化与黏液停滞和肺水肿一致;此外,它们表明,重新利用纠正 CFTR 功能障碍的治疗干预措施可能对治疗 IAV 肺病理生理学有效。

相似文献

5
Liquid movement across the surface epithelium of large airways.液体在大气道表面上皮的移动。
Respir Physiol Neurobiol. 2007 Dec 15;159(3):256-70. doi: 10.1016/j.resp.2007.06.005. Epub 2007 Jun 17.
7
Transgenic hCFTR expression fails to correct β-ENaC mouse lung disease.转染 hCFTR 表达未能纠正 β-ENaC 小鼠肺部疾病。
Am J Physiol Lung Cell Mol Physiol. 2012 Jan 15;302(2):L238-47. doi: 10.1152/ajplung.00083.2011. Epub 2011 Oct 14.

引用本文的文献

4
CFTR as a therapeutic target for severe lung infection.囊性纤维化跨膜传导调节因子作为严重肺部感染的治疗靶点。
Am J Physiol Lung Cell Mol Physiol. 2025 Feb 1;328(2):L229-L238. doi: 10.1152/ajplung.00289.2024. Epub 2025 Jan 8.

本文引用的文献

3
An update on new and emerging therapies for cystic fibrosis.囊性纤维化新型和新兴疗法的最新进展。
Expert Opin Emerg Drugs. 2017 Dec;22(4):331-346. doi: 10.1080/14728214.2017.1418324. Epub 2017 Dec 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验